ImmPACT Bio USA Inc. Raises $18 Million In Series A Financing

GentiBio Launches with $20 Million Seed Funding from Novartis and Others

Kymera Therapeutics Unveils IPO Pitch for Protein Degradation

Sanofi Pays Kymera $150M to Kick Off Protein Degrader Partnership

C4 Therapeutics Adds $170M to Test Protein Degraders in the Clinic

Cambridge biotech launches with $50M to target 'junk DNA'

With $45M Nurix Deal, Gilead Enters Crowded Protein Degradation Field

InFarm Joins Vertical Farming Pantheon With Titanic $100m Series B

UK Immune Cell Therapy Biotech Founded with €40M Series A

Vertex pays Kymera $70M upfront to discover protein degradation drugs

Servier launches U.S. cancer business with plans to double headcount in next 5 years

Ninjacart Raises $89m from Tiger Global in India’s Largest-Ever Farm Tech Deal

AbbVie hands Voyager a mega-billions gene therapy deal, with $310M in near-term cash

AbbVie puts up $105M for Tizona's preclinical I/O drug

The top 20 preclinical biotech deals ranked by cash upfront reveals 3 big players — and some major l

A 1.2 Bilion Gene Therapy Deal

The Bristol-Celgene merger is approved. Here are 8 challenges ahead